ATG7 and glioma: Inhibiting autophagy in vivo by administration of synthetic protein nanoparticles encapsulating siRNA targeting Atg7 sensitized mIDH1 glioma cells to radiation, resulting in tumor regression, long-term survival, and immunological memory.